[go: up one dir, main page]

IN2012DN02675A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02675A
IN2012DN02675A IN2675DEN2012A IN2012DN02675A IN 2012DN02675 A IN2012DN02675 A IN 2012DN02675A IN 2675DEN2012 A IN2675DEN2012 A IN 2675DEN2012A IN 2012DN02675 A IN2012DN02675 A IN 2012DN02675A
Authority
IN
India
Prior art keywords
met
cess
indazol
dicyano
pro
Prior art date
Application number
Inventor
Michels Martin
Follmann Markus
Vakalopoulos Alexandros
Zimmermann Katja
Teusch Nicole
Lobell Mario
Bierer Donald
Engel Karen
Kissel Maria
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2012DN02675A publication Critical patent/IN2012DN02675A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention relates to novel fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-di-methyl-l,4-dihydropyridine derivatives having protein tyrosine kinase inhibitory activity, to a pro¬cess for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions, particularly cancer and other proliferative disorders.
IN2675DEN2012 2009-10-06 2010-10-01 IN2012DN02675A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172304 2009-10-06
PCT/EP2010/064648 WO2011042368A1 (en) 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Publications (1)

Publication Number Publication Date
IN2012DN02675A true IN2012DN02675A (en) 2015-09-04

Family

ID=43357944

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2675DEN2012 IN2012DN02675A (en) 2009-10-06 2010-10-01

Country Status (27)

Country Link
US (1) US9422263B2 (en)
EP (1) EP2485726B1 (en)
JP (1) JP5753175B2 (en)
KR (1) KR20120091005A (en)
CN (1) CN102573838B (en)
AR (1) AR078486A1 (en)
AU (1) AU2010305550A1 (en)
BR (1) BR112012006842A2 (en)
CA (1) CA2773676C (en)
CL (1) CL2012000753A1 (en)
CR (1) CR20120150A (en)
CU (1) CU20120051A7 (en)
DO (1) DOP2012000085A (en)
EC (1) ECSP12011748A (en)
ES (1) ES2458117T3 (en)
IL (1) IL218415A0 (en)
IN (1) IN2012DN02675A (en)
MX (1) MX2012003603A (en)
NZ (1) NZ599006A (en)
PE (1) PE20121392A1 (en)
PH (1) PH12012500640A1 (en)
RU (1) RU2012111695A (en)
SG (1) SG178990A1 (en)
TW (1) TW201124396A (en)
UY (1) UY32922A (en)
WO (1) WO2011042368A1 (en)
ZA (1) ZA201201524B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650179Y2 (en) 1989-06-01 1994-12-21 株式会社プラコー Die head for blow molding machine
JPH0756186Y2 (en) 1989-07-24 1995-12-25 株式会社日本製鋼所 Parison extrusion equipment
JP2781376B2 (en) 1996-06-17 1998-07-30 エクセル株式会社 Hollow molded products
DE102009056886A1 (en) * 2009-12-03 2011-06-09 Bayer Schering Pharma Aktiengesellschaft cMet inhibitors for the treatment of endometriosis
FI3924340T3 (en) 2019-02-11 2025-03-03 Merck Patent Gmbh INDAZOLYLISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635977A (en) 1969-11-03 1972-01-18 American Cyanamid Co Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil
DE59009485D1 (en) 1989-01-26 1995-09-14 Bayer Ag Optically active (meth) acrylic acid derivatives, their preparation, their polymerization into optically active polymers and their use.
DE19546136A1 (en) 1995-12-11 1997-06-12 Bayer Ag Chiral stationary phases for the chromatographic separation of optical isomers
IL164209A0 (en) 2002-05-31 2005-12-18 Eisai Co Ltd Pyrazole derivatives and pharmaceutical compositions containing the same
US20070185152A1 (en) 2004-03-02 2007-08-09 Smithkline Beecham Corporation Inhibitors of akt activity
EP1722792A1 (en) 2004-03-03 2006-11-22 Boehringer Ingelheim International GmbH Selected cgrp-antagonists, method for the production and use thereof as medicaments
RU2007126551A (en) 2004-12-13 2009-01-20 Айрм Ллк (Bm) COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID RECEPTORS AND ACTIVITY OF CALCIUM CHANNELS
EP1858325A4 (en) 2005-01-07 2010-06-30 Roskamp Res Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
WO2006078575A2 (en) * 2005-01-19 2006-07-27 Merck & Co., Inc. Fluorinated aminoalkyl-4-oxo-3,4-dihydropyrido[3,4- d] pyrimidines as inhibitors of mitotic kinesins
UY30779A1 (en) * 2006-12-14 2008-07-31 Bayer Schering Pharma Ag USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE

Also Published As

Publication number Publication date
PE20121392A1 (en) 2012-10-14
JP2013506699A (en) 2013-02-28
RU2012111695A (en) 2013-10-10
CL2012000753A1 (en) 2012-09-14
AU2010305550A1 (en) 2012-03-29
CN102573838B (en) 2014-09-24
HK1172835A1 (en) 2013-05-03
CR20120150A (en) 2012-08-03
ECSP12011748A (en) 2012-05-30
CA2773676A1 (en) 2011-04-14
UY32922A (en) 2011-04-29
ZA201201524B (en) 2013-05-29
CN102573838A (en) 2012-07-11
WO2011042368A1 (en) 2011-04-14
AR078486A1 (en) 2011-11-09
US20120264785A1 (en) 2012-10-18
IL218415A0 (en) 2012-04-30
SG178990A1 (en) 2012-04-27
US9422263B2 (en) 2016-08-23
MX2012003603A (en) 2012-04-20
NZ599006A (en) 2013-11-29
KR20120091005A (en) 2012-08-17
DOP2012000085A (en) 2012-07-15
JP5753175B2 (en) 2015-07-22
ES2458117T3 (en) 2014-04-30
EP2485726B1 (en) 2014-03-12
EP2485726A1 (en) 2012-08-15
BR112012006842A2 (en) 2016-06-07
PH12012500640A1 (en) 2012-11-12
TW201124396A (en) 2011-07-16
CU20120051A7 (en) 2012-06-29
CA2773676C (en) 2017-07-04

Similar Documents

Publication Publication Date Title
MY148851A (en) Dihydropyridine derivatives as useful as protein kinase inhibitors
WO2008124849A3 (en) Pyrrolo-pyridine kinase modulators
WO2007106236A3 (en) Pyrrolo-pyridine kinase modulators
TN2012000081A1 (en) Compounds and compositions as protein kinase inhibitors
GEP20146101B (en) Pyridine and pyrazine derivatives as protein kinase modulators
WO2010083207A3 (en) Protein kinase c inhibitors and uses thereof
MX2009011951A (en) Compounds and compositions as c-kit and pdgfr kinase inhibitors.
WO2011014795A3 (en) Compounds and compositions as syk kinase inhibitors
WO2009097287A9 (en) Compounds and compositions as kinase inhibitors
MX2009007944A (en) Compounds and compositions as kinase inhibitors.
MX2009004716A (en) Compounds and compositions as protein kinase inhibitors.
MX2009012623A (en) Heterocyclic kinase modulators.
MXPA05010711A (en) Novel compounds and compositions as protein kinase inhibitors.
PH12015501806A1 (en) Novel benzopyran kinase modulators
EA201270480A1 (en) NEW CONNECTIONS
MX2009011950A (en) Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors.
MX2009006170A (en) Compounds and compositions as kinase inhibitors.
MX2009011952A (en) Compounds and compositions as c-kit and pdgfr kinase inhibitors.
ATE523510T1 (en) SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHHYRIDINES AND THEIR USE
CU20110215A7 (en) SUBSTITUTED PIPERIDINS
IN2012DN02675A (en)
WO2010129048A3 (en) Therapeutic compounds
CO6470822A2 (en) SUITUATED PIPERIDINS
ATE540042T1 (en) ANNATED 4-(INDAZOLYL)-1,4-DIHYDROPYRIDINE DERIVATIVES AS C-MET MEDIATORS